• DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi logo
  • DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > About

Scientific articles

Home > About

Scientific articles

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

By Disease

Topic

By Topic

Location

By Location

Date Range

By Year

1999 — 2021

Results

No results found. Please try using different filter option(s).

Statements
24 May 2022

DNDi interventions at the 75th World Health Assembly

Hand holding pill
Publications
23 May 2022

Best science for all

Laboratory activities
Press releases
18 May 2022

Consortium formed to discover antivirals for COVID-19 receives NIH funding to develop globally accessible treatments for pandemics

Researcher working in a laboratory setting
News
18 May 2022

Health Journalists from Africa receive grants to report on COVID-19

In the media
16 May 2022

“Faire des produits de santé un bien commun mondial” interview avec Jean-Francois Alesandrini

RFI Priorité Santé
In the media
6 May 2022

Reusing and repurposing data for future pandemics

Health Policy Watch
In the media
5 May 2022

Enfin des médicaments contre les maladies négligées !

Alternatives Economiques
In the media
30 Apr 2022

Move to take measures to eradicate dengue in Malaysia by 2030

The Star
After a serious outbreak of dengue fever in the Chinatown area of Bangkok in which a man died, the Bangkok Metropolitan Administration came in to fumigate the area and advise locals on possible breeding ground of mosquitos.
Press Releases Translations
29 Apr 2022

Kerjasama antara Kementerian Kesihatan Malaysia dengan Drugs for Neglected Diseases initiative bagi memimpin usaha memerangi wabak denggi

After a serious outbreak of dengue fever in the Chinatown area of Bangkok in which a man died, the Bangkok Metropolitan Administration came in to fumigate the area and advise locals on possible breeding ground of mosquitos.
Press Releases Translations
29 Apr 2022

กระทรวงสาธารณสุข มาเลเซีย และ Drugs for Neglected Diseases initiative ผนึกกำลังเพื่อสู้กับโรคไข้เลือดออก

After a serious outbreak of dengue fever in the Chinatown area of Bangkok in which a man died, the Bangkok Metropolitan Administration came in to fumigate the area and advise locals on possible breeding ground of mosquitos.
Press releases
29 Apr 2022

Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue

In the media
26 Apr 2022

The tropical disease ignored for too long

BBC
In the media
26 Apr 2022

Rollout of new effective COVID pill mirrors the “injustice of vaccine apartheid” in poor countries

Salon
In the media
25 Apr 2022

After a COVID expert struggled to obtain new treatments for his parents, he tweeted a road map

The New Yorker
News
22 Apr 2022

DNDi calls for nominations for a new Audit Committee Member

In the media
22 Apr 2022

Invest in malaria and NTDs to fight future disease outbreaks

Media Planet
loading
Loading...
Scientific articles
14 Apr 2022

Understanding individual motivations among members of online communities

Les Cahiers du Numérique
Scientific articles
15 Mar 2022

Development and introduction of fexinidazole into the Global Human African Trypanosomiasis Program

The American Journal of Tropical Medicine and Hygiene
Scientific articles
14 Mar 2022

The pandemic response box ─ accelerating drug discovery efforts after disease outbreaks

ACS Infectious Diseases
Scientific articles
10 Mar 2022

Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside

PLOS Neglected Tropical Diseases
Scientific articles
7 Mar 2022

A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World

PLOS Neglected Tropical Diseases
Scientific articles
3 Mar 2022

Open Synthesis Network research in an undergraduate laboratory: Development of benzoxazole amide derivatives against leishmania parasite

Journal of Chemical Education
Scientific articles
15 Feb 2022

CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding

Nature Reviews Chemistry
Scientific articles
15 Feb 2022

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

Nature Communications
Scientific articles
11 Feb 2022

AmBisome monotherapy and combination AmBisome – miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: A randomised open label, parallel arm, phase III trial

Clinical Infectious Diseases
Scientific articles
9 Feb 2022

Reboot biomedical R&D in the global public interest

Nature
Scientific articles
1 Jan 2022

The silent and dangerous inequity around access to COVID-19 testing: A call to action

EClinicalMedicine
Scientific articles
24 Dec 2021

Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study

BMJ Open
Scientific articles
21 Dec 2021

Interruption of mother-to-child transmission and detection and treatment of children of infected mothers as a contribution to eradicate Chagas disease in Europe

Real Academia Nacional de Medicina
Scientific articles
3 Dec 2021

Target 2035 – update on the quest for a probe for every protein

RSC Medicinal Chemistry
Scientific articles
2 Dec 2021

Pharmacokinetics and safety of the abacavir/ lamivudine/ lopinavir/ ritonavir fixed-dose granule formulation (4-in-1) in neonates

Journal of Acquired Immune Deficiency Syndromes
Scientific articles
18 Nov 2021

Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection

Journal of Clinical Microbiology
1 2 … 30 ›

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi logo
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By continuing to browse our website, you are agreeing to our use of cookies.CLOSECOOKIE POLICY